artenimol has been researched along with Sclerosis, Systemic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, D; Li, R; Lu, L; Wang, J; Yan, Q; Yin, H | 1 |
1 other study(ies) available for artenimol and Sclerosis, Systemic
| Article | Year |
|---|---|
Dihydroartemisinin alleviates skin fibrosis and endothelial dysfunction in bleomycin-induced skin fibrosis models.
Topics: Animals; Artemisinins; Bleomycin; Disease Models, Animal; Fibroblasts; Fibrosis; Human Umbilical Vein Endothelial Cells; Humans; Mice; Phosphatidylinositol 3-Kinases; Scleroderma, Systemic; Skin | 2021 |